Clik here to view.
德累斯顿心脏中心成为Imricor的首家商业化临床单位
明尼阿波利斯 (美国商业资讯) — Imricor今天宣布，该公司与德国德累斯顿心脏中心签署Advantage-MR EP记录仪/刺激仪系统并支持Vision-MR器械1的首份商业化合同。该协议将德累斯顿心脏中心置于MRI引导心脏消融临床进展的前沿，使该医院成为成长中的介入心脏磁共振(iCMR)领域的全球领导者。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
AVITA Medical Announces Commencement of Randomized Controlled Clinical Study...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH) (OTCQX: AVMXY), a global regenerative medicine company, today announced that the commencement of a randomized, controlled...
View ArticleAvita Medical First Quarter Fiscal 2019 Quarterly Cash Flow Report and...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, announced that it filed today with the ASX its Appendix 4C – Quarterly...
View ArticleClik here to view.
Gynesonics Technology to Be Featured in Presentations at 2018 American...
REDWOOD CITY, Calif. Gynesonics, a women’s healthcare company focused on the development of advanced minimally invasive solutions for the treatment of uterine conditions, today announced that its...
View ArticleClik here to view.
Leading Burn Surgeons Present Positive RECELL® System Results at 31st Annual...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, today announced that key opinion leaders from five U.S. burn centers...
View ArticleClik here to view.
心臓発作患者での再灌流に先立つ30分間の左心室アンロードに関するFDA承認安全性試験は安全性と実行可能性を確認
シカゴ （ビジネスワイヤ） — アビオメッド（NASDAQ: ABMD）は、FDA承認試験「STEMIドアツーアンローディングの安全性および実行可能性に関するランダム化対照試験」の結果を発表します。試験結果は、心原性ショックを伴わない前壁ST上昇型心筋梗塞（STEMI）を呈する患者で、再灌流に先立ちImpella...
View ArticleClik here to view.
AVITA Medical Announces Hiring of Full U.S. Sales Team of Experienced Burn...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, today announced that it has completed hiring of the U.S. sales team to...
View ArticleClik here to view.
Japan-India collaboration yields a novel treatment method for male urethral...
TOKYO A novel and relatively pain-less treatment method for male urethral stricture using patients own buccal mucosal cells has been reported as successful in four out of six patients. The study has...
View ArticleClik here to view.
日印の協業が尿道狭窄の新規治療法を生み出す
東京 （ビジネスワイヤ） — 患者の頬粘膜細胞を使用した男性尿道狭窄の新規治療法として、痛みが比較的少ない方法が患者6人のうち4人で成功したとの報告がなされました。本研究は、日本の生体材料技術の研究者とインドの泌尿器科医のDr Suryaprakash Vaddiの共同研究の成果として、日本泌尿器科学会の公式誌であるInternational Journal of...
View ArticleClik here to view.
Aptorum Group [APM] to Ring the NASDAQ Stock Market Closing Bell in...
HONG KONG Aptorum Group Limited (“APM”), a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing therapeutic projects and diagnostic...
View ArticleClik here to view.
クック ジャパン 新代表取締役就任のお知らせ
東京都中野区 （ビジネスワイヤ） — Cook Japan株式会社（本社：東京都中野区、以下「クック ジャパン」）は、このほどバリー・トーマス（Barry Thomas）が新たに代表取締役に就任したことを発表いたします。トーマスは、2001年にクック...
View ArticleClik here to view.
STAAR Surgical Expects Fourth Quarter ICL Sales to Rise 42%; China Units...
MONROVIA, Calif. STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today provided preliminary...
View ArticleClik here to view.
Gynesonics Announces Publication of Final SONATA IDE Pivotal Trial Results in...
REDWOOD CITY, Calif. Gynesonics, a women’s healthcare company and the developer of the Sonata® system for the treatment of uterine fibroids (also known as leiomyomas) today announced the publication...
View ArticleClik here to view.
汉瑞祥和Vets First Choice宣布Covetrus董事会人选
纽约州梅尔维尔和缅因州波特兰 (美国商业资讯)–汉瑞祥公司(Henry Schein, Inc., Nasdaq: HSIC)和Vets First Choice今天宣布将组成Covetrus 11人董事会的相关人选。Covetrus是依计划从Henry Schein Animal Health业务分拆并随后与Vets First...
View ArticleClik here to view.
Clik here to view.
AVITA Medical Announces Nine RECELL® System Abstracts Accepted for...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, today announced that 26 abstracts highlighting the clinical and cost...
View ArticleAvita Medical Second Quarter Fiscal 2019 Quarterly Cash Flow Report and...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, announced that it filed today with the ASX its Appendix 4C – Quarterly...
View ArticleClik here to view.
Rockwood Equity Partners and SYNEO Team Partner on Management Buyout
WEST PALM BEACH, Fla. Rockwood Equity Partners, a lower middle market private investment firm, announced today that it has completed a management buyout of SYNEO, a provider of manufacturing...
View ArticleClik here to view.
KCI Launches ABTHERA™ Therapy in Japan
SAN ANTONIO KCI, an Acelity Company, today announced the launch of ABTHERA™ Open Abdomen Negative Pressure Therapy in Japan, expanding access to the Company’s surgical portfolio in the country....
View ArticleClik here to view.
リヴァノヴァの無縫合大動脈心臓弁パーシバルが大動脈弁疾患患者の治療を目的に日本で保険収載が承認される
ロンドン （ビジネスワイヤ） — 市場をリードする医療技術企業のリヴァノヴァ（NASDAQ:LIVN）は本日、日本の厚生労働省が、大動脈弁疾患の治療を目的とした当社の無縫合大動脈心臓弁Perceval®（パーシバル）の保険収載を承認したと発表しました。パーシバルが日本の保険制度に加わることで、医師と患者はこの多用途バイオ心臓弁を利用しやすくなります。...
View Article